Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE: 301096)
Health Care · Life Sciences Tools & Services · CN
CN¥49.77
-0.58% today · -11.0% 1Y
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE: 301096) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $802.93M.
Over the last twelve months the share price has lost 11.0%, trading between 35.20 and 77.17.
Tweenvest scores Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. across four factors: quality 57/100, value 64/100, growth 80/100. Its strongest factor is growth.
301096 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $802.93M
- Revenue (TTM)
- $102.90M
- P/E
- —
- EPS
- -0.47
- Dividend yield
- —
- Beta (5Y)
- 0.47
- 52-week high
- CN¥77.17
- 52-week low
- CN¥35.20
- Avg volume (3M)
- —
- Shares outstanding
- 108.45M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF592.20 | +1.09% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.